FDA Issues Guidance On Off-Label Info; Waxman Seeks ‘Re-examination’

Rep. Henry Waxman is calling for the Obama administration to re-examine a final FDA guidance that gives companies a way to distribute journal articles discussing off-label uses for approved medical devices and drugs